Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ArthroCare's Quiet Stock Ride

This article was originally published in Start Up

Executive Summary

ArthroCare's stock is soaring. Following a series of favorable announcements by the company, its price has risen steadily over the past several months, reaching a high of $72.50 on October 29. Arthrocare's most important announcement concerned the settlement of its patent litigation with Johnson & Johnson.

Related Content

Device M&A: The New Acquirers
Devices' Next Generation: An Interview with ArthroCare's Michael Baker
ArthroCare's Next Act
ArthroCare Sews Up an Advantage in Sports Medicine


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts